title: Metabolic and ionic requirements for the axoplasmic transport of dopamine beta-hydroxylase.
abstract: 1. Metabolic and ionic requirements for the intra-axonal transport of dopamine beta-hydroxylase (DBH) were investigated in the cat hypogastric nerve-inferior mesenteric ganglion preparation in vitro by monitoring the enzyme accumulation above a crush, 2-2.5 cm distal to the ganglion.2. DBH accumulation in the proximal segment immediately above the crush increased linearly up to 6 h, during incubation in normal Krebs solution at 37 degrees C. The rate of transport of the enzyme was about 4 mm/h.3. Removal of the ganglion, electrical stimulation or reserpine pretreatment (1-6 days before the experiment) did not modify the rate of DBH accumulation.4. Anoxia and glucose deprivation, singly, did not affect accumulation of DBH; however, the combined treatment of anoxia plus glucose deprivation, or dinitrophenol plus glucose deprivation, very markedly interfered with accumulation.5. Removal of sodium or potassium from Krebs solution markedly inhibited the transport of DBH. Preincubation of the nerve in a high-calcium Krebs solution at 4 degrees C, and then reincubation at 37 degrees C, prevented the enzyme accumulation.6. N-ethylmaleimide, ouabain and oligomycin markedly inhibited the transport of DBH.7. The results suggest that transport of DBH, and therefore of noradrenaline storage vesicles, within the hypogastic nerve is dependent on metabolic energy derived from either glycolysis or oxidative phosphorylation. It is also suggested that the sodium-potassium-activated ATPase may play an important role in the intra-axonal transport of storage vesicles.
mesh_terms: D000251:Adenosine Triphosphatases / Q000037:antagonists & inhibitors; D000818:Animals; D001370:Axonal Transport / Q000187:drug effects; D002118:Calcium / Q000494:pharmacology; D002415:Cats; D003470:Culture Media; D004140:Dinitrophenols / Q000494:pharmacology; D004299:Dopamine beta-Hydroxylase / Q000378:metabolism*; D004558:Electric Stimulation; D005033:Ethylmaleimide / Q000494:pharmacology; D005947:Glucose / Q000378:metabolism; D007001:Hypogastric Plexus; D066298:In Vitro Techniques; D008660:Metabolism / Q000187:drug effects; D009409:Nerve Crush; D009840:Oligomycins / Q000494:pharmacology; D010042:Ouabain / Q000494:pharmacology; D010101:Oxygen Consumption; D011188:Potassium / Q000378:metabolism; D012110:Reserpine / Q000494:pharmacology; D012964:Sodium / Q000378:metabolism
chemical_list: D003470:Culture Media; D004140:Dinitrophenols; D009840:Oligomycins; D010042:Ouabain; D012110:Reserpine; D012964:Sodium; D004299:Dopamine beta-Hydroxylase; D000251:Adenosine Triphosphatases; D005947:Glucose; D005033:Ethylmaleimide; D011188:Potassium; D002118:Calcium